{"protocolSection":{"identificationModule":{"nctId":"NCT02578680","orgStudyIdInfo":{"id":"3475-189"},"secondaryIdInfos":[{"id":"163421","type":"REGISTRY","domain":"JAPIC-CTI"},{"id":"MK-3475-189","type":"OTHER","domain":"MSD"},{"id":"2015-003694-15","type":"EUDRACT_NUMBER"}],"organization":{"fullName":"Merck Sharp & Dohme LLC","class":"INDUSTRY"},"briefTitle":"Study of Pemetrexed+Platinum Chemotherapy With or Without Pembrolizumab (MK-3475) in Participants With First Line Metastatic Nonsquamous Non-small Cell Lung Cancer (MK-3475-189/KEYNOTE-189)","officialTitle":"A Randomized, Double-Blind, Phase III Study of Platinum+Pemetrexed Chemotherapy With or Without Pembrolizumab (MK-3475) in First Line Metastatic Non-squamous Non-small Cell Lung Cancer Subjects (KEYNOTE-189)"},"statusModule":{"statusVerifiedDate":"2024-09","overallStatus":"COMPLETED","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2016-01-15","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2017-11-08","type":"ACTUAL"},"completionDateStruct":{"date":"2023-06-22","type":"ACTUAL"},"studyFirstSubmitDate":"2015-10-15","studyFirstSubmitQcDate":"2015-10-15","studyFirstPostDateStruct":{"date":"2015-10-19","type":"ESTIMATED"},"resultsFirstSubmitDate":"2018-09-11","resultsFirstSubmitQcDate":"2018-10-29","resultsFirstPostDateStruct":{"date":"2018-11-28","type":"ACTUAL"},"lastUpdateSubmitDate":"2024-09-05","lastUpdatePostDateStruct":{"date":"2024-09-20","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"Merck Sharp & Dohme LLC","class":"INDUSTRY"}},"oversightModule":{"oversightHasDmc":true,"isFdaRegulatedDrug":true,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"This is an efficacy and safety study of pembrolizumab (MK-3475) combined with pemetrexed/platinum chemotherapy versus pemetrexed/platinum chemotherapy alone in participants with advanced or metastatic nonsquamous non-small cell lung cancer (NSCLC) who have not previously received systemic therapy for advanced disease. Participants will be randomly assigned to receive pembrolizumab combined with pemetrexed/platinum (Investigators choice of cisplatin or carboplatin), OR pemetrexed/platinum (Investigators choice of cisplatin or carboplatin).\n\nWith Amendment 10 (effective date 23-Dec-2019), active participants, investigator, and sponsor personnel or delegate(s) involved in the treatment administration or clinical evaluation of the participants will be unblinded, and all participants in the 'control' arm will discontinue saline placebo.\n\nWith Amendment 11 (effective date 31-Jan-2022), once the study objectives have been met or the study has ended, participants will be discontinued from this study and will be enrolled in an extension study to continue protocol-defined assessments and treatment.\n\nThe primary hypothesis is that pembrolizumab in combination with pemetrexed/platinum chemotherapy prolongs Progression-Free Survival (PFS) and Overall Survival (OS) compared to pemetrexed/platinum chemotherapy alone."},"conditionsModule":{"conditions":["Non-Small-Cell Lung Carcinoma"],"keywords":["PD1","PD-1","PDL1","PD-L1","Non-Small-Cell Lung Cancer"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE3"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"QUADRUPLE","whoMasked":["PARTICIPANT","CARE_PROVIDER","INVESTIGATOR","OUTCOMES_ASSESSOR"]}},"enrollmentInfo":{"count":616,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"Pembrolizumab+Pemetrexed+Platinum Chemotherapy Followed by Pembrolizumab+Pemetrexed","type":"EXPERIMENTAL","description":"Participants receive pembrolizumab 200 mg intravenously (IV) PLUS pemetrexed 500 mg/m\\^2 IV (with vitamin supplementation) PLUS cisplatin 75 mg/m\\^2 IV OR carboplatin Area Under the Curve (AUC) 5 IV on Day 1 of every 3-week cycle (Q3W) for 4 cycles followed by pembrolizumab 200 mg IV PLUS pemetrexed 500 mg/m\\^2 IV Q3W until progression. (Participants who receive pembrolizumab 200 mg IV Q3W for up to 2 years but experience disease progression, will be eligible to receive a second course of pembrolizumab monotherapy 200 mg IV Q3W, at the investigator's discretion, for up to 1 additional year.)","interventionNames":["Biological: Pembrolizumab 200 mg","Drug: Cisplatin","Drug: Carboplatin","Drug: Pemetrexed","Dietary Supplement: Folic acid 350-1000 μg","Dietary Supplement: Vitamin B12 1000 μg","Drug: Dexamethasone 4 mg"]},{"label":"Control","type":"ACTIVE_COMPARATOR","description":"Participants receive saline placebo IV PLUS pemetrexed 500 mg/m\\^2 IV (with vitamin supplementation) PLUS cisplatin 75 mg/m\\^2 IV OR carboplatin AUC 5 IV on Day 1 of every 3-week cycle (Q3W) for 4 cycles followed by saline placebo IV PLUS pemetrexed 500 mg/m\\^2 IV Q3W until progression. (Effective 23-Dec-2019, participants will discontinue saline placebo. If documented progression occurs, participants may be able to receive pembrolizumab monotherapy Q3W for the remainder of the study.)","interventionNames":["Drug: Cisplatin","Drug: Carboplatin","Drug: Pemetrexed","Dietary Supplement: Folic acid 350-1000 μg","Dietary Supplement: Vitamin B12 1000 μg","Drug: Dexamethasone 4 mg","Drug: Saline solution"]}],"interventions":[{"type":"BIOLOGICAL","name":"Pembrolizumab 200 mg","description":"IV infusion","armGroupLabels":["Pembrolizumab+Pemetrexed+Platinum Chemotherapy Followed by Pembrolizumab+Pemetrexed"]},{"type":"DRUG","name":"Cisplatin","description":"IV infusion","armGroupLabels":["Control","Pembrolizumab+Pemetrexed+Platinum Chemotherapy Followed by Pembrolizumab+Pemetrexed"]},{"type":"DRUG","name":"Carboplatin","description":"IV infusion","armGroupLabels":["Control","Pembrolizumab+Pemetrexed+Platinum Chemotherapy Followed by Pembrolizumab+Pemetrexed"]},{"type":"DRUG","name":"Pemetrexed","description":"IV infusion","armGroupLabels":["Control","Pembrolizumab+Pemetrexed+Platinum Chemotherapy Followed by Pembrolizumab+Pemetrexed"]},{"type":"DIETARY_SUPPLEMENT","name":"Folic acid 350-1000 μg","description":"Orally; at least 5 doses of folic acid must be taken during the 7 days preceding the first dose of pemetrexed, and folic acid dosing must continue during the full course of therapy and for 21 days after the last dose of pemetrexed.","armGroupLabels":["Control","Pembrolizumab+Pemetrexed+Platinum Chemotherapy Followed by Pembrolizumab+Pemetrexed"]},{"type":"DIETARY_SUPPLEMENT","name":"Vitamin B12 1000 μg","description":"Intramuscular injection in the week preceding the first dose of pemetrexed and once every 3 cycles thereafter. Subsequent vitamin B12 injections may be given the same day as pemetrexed administration.","armGroupLabels":["Control","Pembrolizumab+Pemetrexed+Platinum Chemotherapy Followed by Pembrolizumab+Pemetrexed"]},{"type":"DRUG","name":"Dexamethasone 4 mg","description":"For prophylaxis; orally twice per day (or equivalent). Taken the day before, day of, and day after pemetrexed administration.","armGroupLabels":["Control","Pembrolizumab+Pemetrexed+Platinum Chemotherapy Followed by Pembrolizumab+Pemetrexed"]},{"type":"DRUG","name":"Saline solution","description":"IV infusion","armGroupLabels":["Control"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Progression-Free Survival (PFS) Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 as Assessed by Blinded Central Imaging","description":"PFS was defined as the time from randomization to the first documented progressive disease (PD) or death due to any cause, whichever occurred first. Per RECIST 1.1, PD was defined as ≥20% increase in the sum of diameters of target lesions, taking as reference the smallest sum on study. In addition to the relative increase of 20%, the sum must also demonstrate an absolute increase of ≥5 mm. Note: The appearance of one or more new lesions was also considered PD. The PFS per RECIST 1.1 is presented.","timeFrame":"Up to approximately 21 months"},{"measure":"Overall Survival (OS)","description":"OS was defined as the time from randomization to death due to any cause. Participants without documented death at the time of the interim analysis were censored at the date of the last follow-up. The OS is presented.","timeFrame":"Up to approximately 21 months"}],"secondaryOutcomes":[{"measure":"Overall Response Rate (ORR) Per RECIST 1.1 as Assessed by Blinded Central Imaging","description":"ORR was defined as the percentage of participants in the analysis population who had a Complete Response (CR: Disappearance of all target lesions) or a Partial Response (PR: ≥30% decrease in the sum of diameters of target lesions, taking as reference the baseline sum diameters) per RECIST 1.1. The percentage of participants who experienced a CR or PR is presented.","timeFrame":"Up to approximately 21 months"},{"measure":"Duration of Response (DOR) Per RECIST 1.1 as Assessed by Blinded Central Imaging","description":"For participants who demonstrated a confirmed CR (disappearance of all target lesions) or PR (≥30% decrease in the sum of diameters of target lesions) per RECIST 1.1, DOR was defined as the time from first documented evidence of a CR or PR until PD or death. DOR for participants who had not progressed or died at the time of analysis was to be censored at the date of their last tumor assessment. Per RECIST 1.1, PD was defined as ≥20% increase in the sum of diameters of target lesions. In addition to the relative increase of 20%, the sum must also have demonstrated an absolute increase of ≥5 mm. Note: The appearance of one or more new lesions was also considered PD. DOR assessments were based on blinded central imaging review with confirmation. The DOR per RECIST 1.1 for all participants who experienced a confirmed CR or PR is presented.","timeFrame":"Up to approximately 21 months"},{"measure":"Number of Participants Who Experienced an Adverse Event (AE)","description":"An AE was defined as any untoward medical occurrence in a study participant administered study drug and which does not necessarily have to have a causal relationship with this study drug. The number of participants who experienced an AE is presented.","timeFrame":"Up to approximately 21 months (Serious AEs: Up to 90 days after last dose of study treatment; Other AEs: Up to 30 days after last dose of study treatment)"},{"measure":"Number of Participants Who Discontinued Any Study Drug Due to an AE","description":"An AE was defined as any untoward medical occurrence in a study participant administered study drug and which does not necessarily have to have a causal relationship with this study drug. The number of participants who discontinued any randomized study drug due to an AE is presented.","timeFrame":"Up to approximately 21 months"}],"otherOutcomes":[{"measure":"Progression-Free Survival (PFS) as Assessed by Investigator Immune-related RECIST (irRECIST) Response Criteria","description":"PFS was defined as the time from randomization to the first documented immune-related progressive disease (irPD) or death due to any cause, whichever occurred first. Per irRECIST, irPD was confirmed if any of the following are observed in 2 scans performed at least 4 weeks apart: target lesion sum of diameters remains ≥20 % and at least 5 mm absolute increase compared to nadir; non-target disease resulting in initial PD is qualitatively worse; new lesion resulting in initial irPD is qualitatively worse; additional new lesion(s) since last evaluation; or additional new non-target lesion progression since last evaluation. The PFS per irRECIST 1.1 is presented.","timeFrame":"Up to approximately 39 months"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Has a histologically-confirmed or cytologically confirmed diagnosis of stage IV nonsquamous NSCLC.\n* Has confirmation that epidermal growth factor receptor (EGFR) or anaplastic lymphoma kinase (ALK)-directed therapy is not indicated.\n* Has measurable disease.\n* Has not received prior systemic treatment for their advanced/metastatic NSCLC.\n* Can provide tumor tissue.\n* Has a life expectancy of at least 3 months.\n* Has a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) Performance Status.\n* Has adequate organ function\n* If female of childbearing potential, is willing to use adequate contraception for the course of the study through 120 days after the last dose of study medication or through 180 days after last dose of chemotherapeutic agents.\n* If male with a female partner(s) of child-bearing potential, must agree to use adequate contraception starting with the first dose of study medication through 120 days after the last dose of study medication or through 180 days after last dose of chemotherapeutic agents.\n\nExclusion Criteria:\n\n* Has predominantly squamous cell histology NSCLC.\n* Is currently participating and receiving study therapy or has participated in a study of an investigational agent and received study therapy or used an investigational device within 4 weeks prior to administration of pembrolizumab.\n* Before the first dose of study medication: a) Has received prior systemic cytotoxic chemotherapy for metastatic disease, b) Has received antineoplastic biological therapy (e.g., erlotinib, crizotinib, cetuximab), c) Had major surgery (\\<3 weeks prior to first dose)\n* Received radiation therapy to the lung that is \\>30 Gray (Gy) within 6 months of the first dose of study medication.\n* Completed palliative radiotherapy within 7 days of the first dose of study medication.\n* Is expected to require any other form of antineoplastic therapy while on study.\n* Received a live-virus vaccination within 30 days of planned start of study medication.\n* Has clinically active diverticulitis, intra-abdominal abscess, gastrointestinal obstruction, peritoneal carcinomatosis.\n* Known history of prior malignancy except if participant has undergone potentially curative therapy with no evidence of that disease recurrence for 5 years since initiation of that therapy, except for successful definitive resection of basal cell carcinoma of the skin, superficial bladder cancer, squamous cell carcinoma of the skin, in situ cervical cancer, or other in situ cancers.\n* Has known active central nervous system (CNS) metastases and/or carcinomatous meningitis.\n* Previously had a severe hypersensitivity reaction to treatment with another monoclonal antibody (mAb).\n* Known sensitivity to any component of cisplatin, carboplatin or pemetrexed.\n* Has active autoimmune disease that has required systemic treatment in past 2 years.\n* Is on chronic systemic steroids.\n* Is unable to interrupt aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs), other than an aspirin dose ≤1.3 g per day, for a 5-day period (8-day period for long-acting agents, such as piroxicam).\n* Is unable or unwilling to take folic acid or vitamin B12 supplementation.\n* Had prior treatment with any other anti-programmed cell death-1 (PD-1), or PD-ligand 1 (PD-L1) or PD-L2 agent or an antibody targeting other immuno-regulatory receptors or mechanisms. Has participated in any other pembrolizumab study and has been treated with pembrolizumab.\n* Has an active infection requiring therapy.\n* Has known history of Human Immunodeficiency Virus (HIV).\n* Has known active Hepatitis B or C.\n* Has known psychiatric or substance abuse disorder that would interfere with cooperation with the requirements of the trial.\n* Is a regular user (including \"recreational use\") of any illicit drugs or had a recent history (within the last year) of substance abuse (including alcohol).\n* Has symptomatic ascites or pleural effusion.\n* Has interstitial lung disease or a history of pneumonitis that required oral of IV glucocorticoids to assist with management.\n* Is pregnant or breastfeeding, or expecting to conceive or father children prior to 120 days after the last dose of study medication or through 180 days after last dose of chemotherapeutic agents.","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"overallOfficials":[{"name":"Medical Director","affiliation":"Merck Sharp & Dohme LLC","role":"STUDY_DIRECTOR"}]},"referencesModule":{"references":[{"pmid":"40498298","type":"DERIVED","citation":"Garassino MC, Cheng Y, Rodriguez-Abreu D, Novello S, Mazieres J, Robinson AG, Powell SF, Halmos B, Gray JE, Wang M, Chen C, Yang J, Souza F, Schwarzenberger P, Paz-Ares L. Impact of Tumor Response and Response Duration on Survival Among Participants Receiving Pembrolizumab Plus Chemotherapy as First-Line Therapy for Non-Small-Cell Lung Cancer. Oncol Ther. 2025 Sep;13(3):667-681. doi: 10.1007/s40487-025-00350-6. Epub 2025 Jun 11."},{"pmid":"37465924","type":"DERIVED","citation":"Cheng Y, Yang JC, Okamoto I, Zhang L, Hu J, Wang D, Hu C, Zhou J, Wu L, Cao L, Liu J, Zhang H, Sun H, Wang Z, Gao H, Yan Y, Xiao S, Lin J, Pietanza MC, Kurata T. Pembrolizumab plus chemotherapy for advanced non-small-cell lung cancer without tumor PD-L1 expression in Asia. Immunotherapy. 2023 Sep;15(13):1029-1044. doi: 10.2217/imt-2023-0043. Epub 2023 Jul 19."},{"pmid":"36809080","type":"DERIVED","citation":"Garassino MC, Gadgeel S, Speranza G, Felip E, Esteban E, Domine M, Hochmair MJ, Powell SF, Bischoff HG, Peled N, Grossi F, Jennens RR, Reck M, Hui R, Garon EB, Kurata T, Gray JE, Schwarzenberger P, Jensen E, Pietanza MC, Rodriguez-Abreu D. Pembrolizumab Plus Pemetrexed and Platinum in Nonsquamous Non-Small-Cell Lung Cancer: 5-Year Outcomes From the Phase 3 KEYNOTE-189 Study. J Clin Oncol. 2023 Apr 10;41(11):1992-1998. doi: 10.1200/JCO.22.01989. Epub 2023 Feb 21."},{"pmid":"36793385","type":"DERIVED","citation":"Garassino MC, Gadgeel S, Novello S, Halmos B, Felip E, Speranza G, Hui R, Garon EB, Horinouchi H, Sugawara S, Rodriguez-Abreu D, Reck M, Cristescu R, Aurora-Garg D, Loboda A, Lunceford J, Kobie J, Ayers M, Piperdi B, Pietanza MC, Paz-Ares L. Associations of Tissue Tumor Mutational Burden and Mutational Status With Clinical Outcomes With Pembrolizumab Plus Chemotherapy Versus Chemotherapy For Metastatic NSCLC. JTO Clin Res Rep. 2022 Nov 8;4(1):100431. doi: 10.1016/j.jtocrr.2022.100431. eCollection 2023 Jan."},{"pmid":"33730652","type":"DERIVED","citation":"Garon EB, Aerts J, Kim JS, Muehlenbein CE, Peterson P, Rizzo MT, Gadgeel SM. Safety of pemetrexed plus platinum in combination with pembrolizumab for metastatic nonsquamous non-small cell lung cancer: A post hoc analysis of KEYNOTE-189. Lung Cancer. 2021 May;155:53-60. doi: 10.1016/j.lungcan.2021.02.021. Epub 2021 Feb 19."},{"pmid":"32150489","type":"DERIVED","citation":"Gadgeel S, Rodriguez-Abreu D, Speranza G, Esteban E, Felip E, Domine M, Hui R, Hochmair MJ, Clingan P, Powell SF, Cheng SY, Bischoff HG, Peled N, Grossi F, Jennens RR, Reck M, Garon EB, Novello S, Rubio-Viqueira B, Boyer M, Kurata T, Gray JE, Yang J, Bas T, Pietanza MC, Garassino MC. Updated Analysis From KEYNOTE-189: Pembrolizumab or Placebo Plus Pemetrexed and Platinum for Previously Untreated Metastatic Nonsquamous Non-Small-Cell Lung Cancer. J Clin Oncol. 2020 May 10;38(14):1505-1517. doi: 10.1200/JCO.19.03136. Epub 2020 Mar 9."},{"pmid":"32035514","type":"DERIVED","citation":"Garassino MC, Gadgeel S, Esteban E, Felip E, Speranza G, Domine M, Hochmair MJ, Powell S, Cheng SY, Bischoff HG, Peled N, Reck M, Hui R, Garon EB, Boyer M, Wei Z, Burke T, Pietanza MC, Rodriguez-Abreu D. Patient-reported outcomes following pembrolizumab or placebo plus pemetrexed and platinum in patients with previously untreated, metastatic, non-squamous non-small-cell lung cancer (KEYNOTE-189): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial. Lancet Oncol. 2020 Mar;21(3):387-397. doi: 10.1016/S1470-2045(19)30801-0. Epub 2020 Feb 6."},{"pmid":"29658856","type":"DERIVED","citation":"Gandhi L, Rodriguez-Abreu D, Gadgeel S, Esteban E, Felip E, De Angelis F, Domine M, Clingan P, Hochmair MJ, Powell SF, Cheng SY, Bischoff HG, Peled N, Grossi F, Jennens RR, Reck M, Hui R, Garon EB, Boyer M, Rubio-Viqueira B, Novello S, Kurata T, Gray JE, Vida J, Wei Z, Yang J, Raftopoulos H, Pietanza MC, Garassino MC; KEYNOTE-189 Investigators. Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer. N Engl J Med. 2018 May 31;378(22):2078-2092. doi: 10.1056/NEJMoa1801005. Epub 2018 Apr 16."}],"seeAlsoLinks":[{"label":"Merck Clinical Trials Information","url":"https://www.merckclinicaltrials.com/"},{"label":"Plain Language Summary","url":"https://msd.trialsummaries.com/Study/StudyDetails?id=26082&tenant=MT_MSD_9011"}]},"ipdSharingStatementModule":{"ipdSharing":"YES","description":"http://engagezone.msd.com/doc/ProcedureAccessClinicalTrialData.pdf","url":"http://engagezone.msd.com/ds_documentation.php"}},"resultsSection":{"participantFlowModule":{"preAssignmentDetails":"Eighty-four participants randomized to receive Control switched over to receive pembrolizumab monotherapy. Participants receiving pembrolizumab in first course and those switching over from placebo to pembrolizumab monotherapy were eligible to receive second course of pembrolizumab monotherapy if they met certain criteria. Data from second course treatment contributed to safety data only. All primary and secondary outcome measures are based on protocol-specified cutoff (2017-11-08).","groups":[{"id":"FG000","title":"Pembrolizumab+Pemetrexed+Platinum Chemotherapy Followed by Pembrolizumab+Pemetrexed","description":"Participants received pembrolizumab 200 mg IV PLUS pemetrexed 500 mg/m\\^2 IV (with vitamin supplementation) PLUS cisplatin 75 mg/m\\^2 IV OR carboplatin AUC 5 IV on Day 1 of every 3-week cycle (Q3W) for 4 cycles followed by pembrolizumab 200 mg IV PLUS pemetrexed 500 mg/m\\^2 IV Q3W until progression. (Participants who received pembrolizumab 200 mg IV Q3W for up to 2 years but experienced disease progression, were eligible to receive a second course of pembrolizumab monotherapy 200 mg IV Q3W, at the investigator's discretion, for up to 1 additional year.)"},{"id":"FG001","title":"Control","description":"Participants received saline placebo IV PLUS pemetrexed 500 mg/m\\^2 IV (with vitamin supplementation) PLUS cisplatin 75 mg/m\\^2 IV OR carboplatin AUC 5 IV on Day 1 of every 3-week cycle (Q3W) for 4 cycles followed by saline placebo IV PLUS pemetrexed 500 mg/m\\^2 IV Q3W until progression. (Effective 23-Dec-2019, participants discontinued saline placebo. If documented disease progression had occurred, and participants receiving Control met certain criteria, they were eligible to switch over to receive pembrolizumab monotherapy Q3W for the remainder of the study.)"}],"periods":[{"title":"Overall Study","milestones":[{"type":"STARTED","achievements":[{"groupId":"FG000","numSubjects":"410"},{"groupId":"FG001","numSubjects":"206"}]},{"type":"Treated","achievements":[{"groupId":"FG000","numSubjects":"405"},{"groupId":"FG001","numSubjects":"202"}]},{"type":"Switched to Pembrolizumab","achievements":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"84"}]},{"type":"COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"}]},{"type":"NOT COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"410"},{"groupId":"FG001","numSubjects":"206"}]}],"dropWithdraws":[{"type":"Death","reasons":[{"groupId":"FG000","numSubjects":"329"},{"groupId":"FG001","numSubjects":"181"}]},{"type":"Lost to Follow-up","reasons":[{"groupId":"FG000","numSubjects":"3"},{"groupId":"FG001","numSubjects":"1"}]},{"type":"Physician Decision","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"1"}]},{"type":"Protocol Violation","reasons":[{"groupId":"FG000","numSubjects":"1"},{"groupId":"FG001","numSubjects":"1"}]},{"type":"Sponsor Decision","reasons":[{"groupId":"FG000","numSubjects":"64"},{"groupId":"FG001","numSubjects":"13"}]},{"type":"Withdrawal by Subject","reasons":[{"groupId":"FG000","numSubjects":"13"},{"groupId":"FG001","numSubjects":"9"}]}]}]},"baselineCharacteristicsModule":{"populationDescription":"The Baseline Analysis Population consisted of all randomized participants.","groups":[{"id":"BG000","title":"Pembrolizumab+Pemetrexed+Platinum Chemotherapy Followed by Pembrolizumab+Pemetrexed","description":"Participants received pembrolizumab 200 mg IV PLUS pemetrexed 500 mg/m\\^2 IV (with vitamin supplementation) PLUS cisplatin 75 mg/m\\^2 IV OR carboplatin AUC 5 IV on Day 1 of every 3-week cycle (Q3W) for 4 cycles followed by pembrolizumab 200 mg IV PLUS pemetrexed 500 mg/m\\^2 IV Q3W until progression. (Participants who received pembrolizumab 200 mg IV Q3W for up to 2 years but experienced disease progression, were eligible to receive a second course of pembrolizumab monotherapy 200 mg IV Q3W, at the investigator's discretion, for up to 1 additional year.)"},{"id":"BG001","title":"Control","description":"Participants received saline placebo IV PLUS pemetrexed 500 mg/m\\^2 IV (with vitamin supplementation) PLUS cisplatin 75 mg/m\\^2 IV OR carboplatin AUC 5 IV on Day 1 of every 3-week cycle (Q3W) for 4 cycles followed by saline placebo IV PLUS pemetrexed 500 mg/m\\^2 IV Q3W until progression. (Effective 23-Dec-2019, participants discontinued saline placebo. If documented disease progression had occurred, and participants receiving Control met certain criteria, they were eligible to switch over to receive pembrolizumab monotherapy Q3W for the remainder of the study.)"},{"id":"BG002","title":"Total","description":"Total of all reporting groups"}],"denoms":[{"units":"Participants","counts":[{"groupId":"BG000","value":"410"},{"groupId":"BG001","value":"206"},{"groupId":"BG002","value":"616"}]}],"measures":[{"title":"Age, Continuous","paramType":"MEAN","dispersionType":"STANDARD_DEVIATION","unitOfMeasure":"Years","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"63.2","spread":"9.4"},{"groupId":"BG001","value":"62.8","spread":"9.1"},{"groupId":"BG002","value":"63.1","spread":"9.3"}]}]}]},{"title":"Sex: Female, Male","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"title":"Female","measurements":[{"groupId":"BG000","value":"156"},{"groupId":"BG001","value":"97"},{"groupId":"BG002","value":"253"}]},{"title":"Male","measurements":[{"groupId":"BG000","value":"254"},{"groupId":"BG001","value":"109"},{"groupId":"BG002","value":"363"}]}]}]},{"title":"Race (NIH/OMB)","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"title":"American Indian or Alaska Native","measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}]},{"title":"Asian","measurements":[{"groupId":"BG000","value":"10"},{"groupId":"BG001","value":"8"},{"groupId":"BG002","value":"18"}]},{"title":"Native Hawaiian or Other Pacific Islander","measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}]},{"title":"Black or African American","measurements":[{"groupId":"BG000","value":"11"},{"groupId":"BG001","value":"3"},{"groupId":"BG002","value":"14"}]},{"title":"White","measurements":[{"groupId":"BG000","value":"387"},{"groupId":"BG001","value":"195"},{"groupId":"BG002","value":"582"}]},{"title":"More than one race","measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}]},{"title":"Unknown or Not Reported","measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"2"}]}]}]},{"title":"Programmed Cell Death-Ligand 1 (PD-L1) Tumor Status","description":"Participants were assessed for their PD-L1 tumor expression level by immunohistochemistry assay using tumor tissue from an archival or newly obtained biopsy. Participants with a TPS ≥1% were classified as PD-L1 positive and participants with a TPS \\<1% were classified as PD-L1 negative.","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"title":"TPS <1%","categories":[{"measurements":[{"groupId":"BG000","value":"127"},{"groupId":"BG001","value":"63"},{"groupId":"BG002","value":"190"}]}]},{"title":"TPS ≥1%","categories":[{"measurements":[{"groupId":"BG000","value":"260"},{"groupId":"BG001","value":"128"},{"groupId":"BG002","value":"388"}]}]},{"title":"Not Evaluable","categories":[{"measurements":[{"groupId":"BG000","value":"23"},{"groupId":"BG001","value":"15"},{"groupId":"BG002","value":"38"}]}]}]},{"title":"Platinum Chemotherapy","description":"Participants were classified according to the type of platinum chemotherapy the Investigator chose for them to receive: Cisplatin or Carboplatin.","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"title":"Cisplatin","categories":[{"measurements":[{"groupId":"BG000","value":"113"},{"groupId":"BG001","value":"58"},{"groupId":"BG002","value":"171"}]}]},{"title":"Carboplatin","categories":[{"measurements":[{"groupId":"BG000","value":"297"},{"groupId":"BG001","value":"148"},{"groupId":"BG002","value":"445"}]}]}]},{"title":"Smoking Status","description":"Participants were classified according to their smoking status: Never Smoker or Former/Current Smoker.","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"title":"Never Smoker","categories":[{"measurements":[{"groupId":"BG000","value":"48"},{"groupId":"BG001","value":"25"},{"groupId":"BG002","value":"73"}]}]},{"title":"Former/Current Smoker","categories":[{"measurements":[{"groupId":"BG000","value":"362"},{"groupId":"BG001","value":"181"},{"groupId":"BG002","value":"543"}]}]}]}]},"outcomeMeasuresModule":{"outcomeMeasures":[{"type":"PRIMARY","title":"Progression-Free Survival (PFS) Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 as Assessed by Blinded Central Imaging","description":"PFS was defined as the time from randomization to the first documented progressive disease (PD) or death due to any cause, whichever occurred first. Per RECIST 1.1, PD was defined as ≥20% increase in the sum of diameters of target lesions, taking as reference the smallest sum on study. In addition to the relative increase of 20%, the sum must also demonstrate an absolute increase of ≥5 mm. Note: The appearance of one or more new lesions was also considered PD. The PFS per RECIST 1.1 is presented.","populationDescription":"The analysis population consisted of all randomized participants.","reportingStatus":"POSTED","paramType":"MEDIAN","dispersionType":"95% Confidence Interval","unitOfMeasure":"Months","timeFrame":"Up to approximately 21 months","groups":[{"id":"OG000","title":"Pembrolizumab+Pemetrexed+Platinum Chemotherapy Followed by Pembrolizumab+Pemetrexed","description":"Participants received pembrolizumab 200 mg IV PLUS pemetrexed 500 mg/m\\^2 IV (with vitamin supplementation) PLUS cisplatin 75 mg/m\\^2 IV OR carboplatin AUC 5 IV on Day 1 of every 3-week cycle (Q3W) for 4 cycles followed by pembrolizumab 200 mg IV PLUS pemetrexed 500 mg/m\\^2 IV Q3W until progression. (Participants who received pembrolizumab 200 mg IV Q3W for up to 2 years but experienced disease progression, were eligible to receive a second course of pembrolizumab monotherapy 200 mg IV Q3W, at the investigator's discretion, for up to 1 additional year.)"},{"id":"OG001","title":"Control","description":"Participants received saline placebo IV PLUS pemetrexed 500 mg/m\\^2 IV (with vitamin supplementation) PLUS cisplatin 75 mg/m\\^2 IV OR carboplatin AUC 5 IV on Day 1 of every 3-week cycle (Q3W) for 4 cycles followed by saline placebo IV PLUS pemetrexed 500 mg/m\\^2 IV Q3W until progression. (Effective 23-Dec-2019, participants discontinued saline placebo. If documented disease progression had occurred, and participants receiving Control met certain criteria, they were eligible to switch over to receive pembrolizumab monotherapy Q3W for the remainder of the study.)"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"410"},{"groupId":"OG001","value":"206"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"8.8","lowerLimit":"7.6","upperLimit":"9.2"},{"groupId":"OG001","value":"4.9","lowerLimit":"4.7","upperLimit":"5.5"}]}]}],"analyses":[{"groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY","pValue":"<0.00001","statisticalMethod":"Log Rank","paramType":"Hazard Ratio (HR)","paramValue":"0.52","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"0.43","ciUpperLimit":"0.64","estimateComment":"Based on Cox regression model with treatment as a covariate stratified by PD-L1 status (≥1% vs. \\<1%), platinum chemotherapy (cisplatin vs. carboplatin) \\& smoking status (never vs. former/current). Pembrolizumab=numerator; Control=denominator."}]},{"type":"PRIMARY","title":"Overall Survival (OS)","description":"OS was defined as the time from randomization to death due to any cause. Participants without documented death at the time of the interim analysis were censored at the date of the last follow-up. The OS is presented.","populationDescription":"The analysis population consisted of all randomized participants.","reportingStatus":"POSTED","paramType":"MEDIAN","dispersionType":"95% Confidence Interval","unitOfMeasure":"Months","timeFrame":"Up to approximately 21 months","groups":[{"id":"OG000","title":"Pembrolizumab+Pemetrexed+Platinum Chemotherapy Followed by Pembrolizumab+Pemetrexed","description":"Participants received pembrolizumab 200 mg IV PLUS pemetrexed 500 mg/m\\^2 IV (with vitamin supplementation) PLUS cisplatin 75 mg/m\\^2 IV OR carboplatin AUC 5 IV on Day 1 of every 3-week cycle (Q3W) for 4 cycles followed by pembrolizumab 200 mg IV PLUS pemetrexed 500 mg/m\\^2 IV Q3W until progression. (Participants who received pembrolizumab 200 mg IV Q3W for up to 2 years but experienced disease progression, were eligible to receive a second course of pembrolizumab monotherapy 200 mg IV Q3W, at the investigator's discretion, for up to 1 additional year.)"},{"id":"OG001","title":"Control","description":"Participants received saline placebo IV PLUS pemetrexed 500 mg/m\\^2 IV (with vitamin supplementation) PLUS cisplatin 75 mg/m\\^2 IV OR carboplatin AUC 5 IV on Day 1 of every 3-week cycle (Q3W) for 4 cycles followed by saline placebo IV PLUS pemetrexed 500 mg/m\\^2 IV Q3W until progression. (Effective 23-Dec-2019, participants discontinued saline placebo. If documented disease progression had occurred, and participants receiving Control met certain criteria, they were eligible to switch over to receive pembrolizumab monotherapy Q3W for the remainder of the study.)"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"410"},{"groupId":"OG001","value":"206"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"NA","lowerLimit":"NA","upperLimit":"NA","comment":"NA=Median OS not reached NA=Lower Limit OS not reached NA=Upper Limit OS not reached"},{"groupId":"OG001","value":"11.3","lowerLimit":"8.7","upperLimit":"15.1"}]}]}],"analyses":[{"groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY","pValue":"<0.00001","statisticalMethod":"Log Rank","paramType":"Hazard Ratio (HR)","paramValue":"0.49","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"0.38","ciUpperLimit":"0.64","estimateComment":"Based on Cox regression model with treatment as a covariate stratified by PD-L1 status (≥1% vs. \\<1%), platinum chemotherapy (cisplatin vs. carboplatin) \\& smoking status (never vs. former/current). Pembrolizumab=numerator; Control=denominator."}]},{"type":"SECONDARY","title":"Overall Response Rate (ORR) Per RECIST 1.1 as Assessed by Blinded Central Imaging","description":"ORR was defined as the percentage of participants in the analysis population who had a Complete Response (CR: Disappearance of all target lesions) or a Partial Response (PR: ≥30% decrease in the sum of diameters of target lesions, taking as reference the baseline sum diameters) per RECIST 1.1. The percentage of participants who experienced a CR or PR is presented.","populationDescription":"The analysis population consisted of all randomized participants.","reportingStatus":"POSTED","paramType":"NUMBER","dispersionType":"95% Confidence Interval","unitOfMeasure":"Percentage of Participants","timeFrame":"Up to approximately 21 months","groups":[{"id":"OG000","title":"Pembrolizumab+Pemetrexed+Platinum Chemotherapy Followed by Pembrolizumab+Pemetrexed","description":"Participants received pembrolizumab 200 mg IV PLUS pemetrexed 500 mg/m\\^2 IV (with vitamin supplementation) PLUS cisplatin 75 mg/m\\^2 IV OR carboplatin AUC 5 IV on Day 1 of every 3-week cycle (Q3W) for 4 cycles followed by pembrolizumab 200 mg IV PLUS pemetrexed 500 mg/m\\^2 IV Q3W until progression. (Participants who received pembrolizumab 200 mg IV Q3W for up to 2 years but experienced disease progression, were eligible to receive a second course of pembrolizumab monotherapy 200 mg IV Q3W, at the investigator's discretion, for up to 1 additional year.)"},{"id":"OG001","title":"Control","description":"Participants received saline placebo IV PLUS pemetrexed 500 mg/m\\^2 IV (with vitamin supplementation) PLUS cisplatin 75 mg/m\\^2 IV OR carboplatin AUC 5 IV on Day 1 of every 3-week cycle (Q3W) for 4 cycles followed by saline placebo IV PLUS pemetrexed 500 mg/m\\^2 IV Q3W until progression. (Effective 23-Dec-2019, participants discontinued saline placebo. If documented disease progression had occurred, and participants receiving Control met certain criteria, they were eligible to switch over to receive pembrolizumab monotherapy Q3W for the remainder of the study.)"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"410"},{"groupId":"OG001","value":"206"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"47.6","lowerLimit":"42.6","upperLimit":"52.5"},{"groupId":"OG001","value":"18.9","lowerLimit":"13.8","upperLimit":"25.0"}]}]}],"analyses":[{"groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY","pValue":"<0.0001","pValueComment":"H0:Difference in percentages=0 vs H1:Difference in percentages\\>0","statisticalMethod":"Stratified Miettinen and Nurminen","paramType":"Difference in Percentage vs. Control","paramValue":"28.5","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"21.1","ciUpperLimit":"35.4","estimateComment":"Miettinen and Nurminen method with treatment as a covariate stratified by PD-L1 status (≥1% vs. \\<1%), platinum chemotherapy (cisplatin vs. carboplatin) \\& smoking status (never vs. former/current). Pembrolizumab=numerator; Control=denominator."}]},{"type":"SECONDARY","title":"Duration of Response (DOR) Per RECIST 1.1 as Assessed by Blinded Central Imaging","description":"For participants who demonstrated a confirmed CR (disappearance of all target lesions) or PR (≥30% decrease in the sum of diameters of target lesions) per RECIST 1.1, DOR was defined as the time from first documented evidence of a CR or PR until PD or death. DOR for participants who had not progressed or died at the time of analysis was to be censored at the date of their last tumor assessment. Per RECIST 1.1, PD was defined as ≥20% increase in the sum of diameters of target lesions. In addition to the relative increase of 20%, the sum must also have demonstrated an absolute increase of ≥5 mm. Note: The appearance of one or more new lesions was also considered PD. DOR assessments were based on blinded central imaging review with confirmation. The DOR per RECIST 1.1 for all participants who experienced a confirmed CR or PR is presented.","populationDescription":"The analysis population consisted of all randomized participants who experienced a confirmed CR or confirmed PR.","reportingStatus":"POSTED","paramType":"MEDIAN","dispersionType":"Full Range","unitOfMeasure":"Months","timeFrame":"Up to approximately 21 months","groups":[{"id":"OG000","title":"Pembrolizumab+Pemetrexed+Platinum Chemotherapy Followed by Pembrolizumab+Pemetrexed","description":"Participants received pembrolizumab 200 mg IV PLUS pemetrexed 500 mg/m\\^2 IV (with vitamin supplementation) PLUS cisplatin 75 mg/m\\^2 IV OR carboplatin AUC 5 IV on Day 1 of every 3-week cycle (Q3W) for 4 cycles followed by pembrolizumab 200 mg IV PLUS pemetrexed 500 mg/m\\^2 IV Q3W until progression. (Participants who received pembrolizumab 200 mg IV Q3W for up to 2 years but experienced disease progression, were eligible to receive a second course of pembrolizumab monotherapy 200 mg IV Q3W, at the investigator's discretion, for up to 1 additional year.)"},{"id":"OG001","title":"Control","description":"Participants received saline placebo IV PLUS pemetrexed 500 mg/m\\^2 IV (with vitamin supplementation) PLUS cisplatin 75 mg/m\\^2 IV OR carboplatin AUC 5 IV on Day 1 of every 3-week cycle (Q3W) for 4 cycles followed by saline placebo IV PLUS pemetrexed 500 mg/m\\^2 IV Q3W until progression. (Effective 23-Dec-2019, participants discontinued saline placebo. If documented disease progression had occurred, and participants receiving Control met certain criteria, they were eligible to switch over to receive pembrolizumab monotherapy Q3W for the remainder of the study.)"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"195"},{"groupId":"OG001","value":"39"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"11.2","lowerLimit":"1.1","upperLimit":"18.0"},{"groupId":"OG001","value":"7.8","lowerLimit":"2.1","upperLimit":"16.4"}]}]}]},{"type":"SECONDARY","title":"Number of Participants Who Experienced an Adverse Event (AE)","description":"An AE was defined as any untoward medical occurrence in a study participant administered study drug and which does not necessarily have to have a causal relationship with this study drug. The number of participants who experienced an AE is presented.","populationDescription":"The analysis population consisted of all randomized participants who received ≥1 dose of study drug.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"Up to approximately 21 months (Serious AEs: Up to 90 days after last dose of study treatment; Other AEs: Up to 30 days after last dose of study treatment)","groups":[{"id":"OG000","title":"Pembrolizumab+Pemetrexed+Platinum Chemotherapy Followed by Pembrolizumab+Pemetrexed","description":"Participants received pembrolizumab 200 mg IV PLUS pemetrexed 500 mg/m\\^2 IV (with vitamin supplementation) PLUS cisplatin 75 mg/m\\^2 IV OR carboplatin AUC 5 IV on Day 1 of every 3-week cycle (Q3W) for 4 cycles followed by pembrolizumab 200 mg IV PLUS pemetrexed 500 mg/m\\^2 IV Q3W until progression. (Participants who received pembrolizumab 200 mg IV Q3W for up to 2 years but experienced disease progression, were eligible to receive a second course of pembrolizumab monotherapy 200 mg IV Q3W, at the investigator's discretion, for up to 1 additional year.)"},{"id":"OG001","title":"Control","description":"Participants received saline placebo IV PLUS pemetrexed 500 mg/m\\^2 IV (with vitamin supplementation) PLUS cisplatin 75 mg/m\\^2 IV OR carboplatin AUC 5 IV on Day 1 of every 3-week cycle (Q3W) for 4 cycles followed by saline placebo IV PLUS pemetrexed 500 mg/m\\^2 IV Q3W until progression. (Effective 23-Dec-2019, participants discontinued saline placebo. If documented disease progression had occurred, and participants receiving Control met certain criteria, they were eligible to switch over to receive pembrolizumab monotherapy Q3W for the remainder of the study.)"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"405"},{"groupId":"OG001","value":"202"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"404"},{"groupId":"OG001","value":"200"}]}]}]},{"type":"SECONDARY","title":"Number of Participants Who Discontinued Any Study Drug Due to an AE","description":"An AE was defined as any untoward medical occurrence in a study participant administered study drug and which does not necessarily have to have a causal relationship with this study drug. The number of participants who discontinued any randomized study drug due to an AE is presented.","populationDescription":"The analysis population consisted of all randomized participants who received ≥1 dose of study drug.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"Up to approximately 21 months","groups":[{"id":"OG000","title":"Pembrolizumab+Pemetrexed+Platinum Chemotherapy Followed by Pembrolizumab+Pemetrexed","description":"Participants received pembrolizumab 200 mg IV PLUS pemetrexed 500 mg/m\\^2 IV (with vitamin supplementation) PLUS cisplatin 75 mg/m\\^2 IV OR carboplatin AUC 5 IV on Day 1 of every 3-week cycle (Q3W) for 4 cycles followed by pembrolizumab 200 mg IV PLUS pemetrexed 500 mg/m\\^2 IV Q3W until progression. (Participants who received pembrolizumab 200 mg IV Q3W for up to 2 years but experienced disease progression, were eligible to receive a second course of pembrolizumab monotherapy 200 mg IV Q3W, at the investigator's discretion, for up to 1 additional year.)"},{"id":"OG001","title":"Control","description":"Participants received saline placebo IV PLUS pemetrexed 500 mg/m\\^2 IV (with vitamin supplementation) PLUS cisplatin 75 mg/m\\^2 IV OR carboplatin AUC 5 IV on Day 1 of every 3-week cycle (Q3W) for 4 cycles followed by saline placebo IV PLUS pemetrexed 500 mg/m\\^2 IV Q3W until progression. (Effective 23-Dec-2019, participants discontinued saline placebo. If documented disease progression had occurred, and participants receiving Control met certain criteria, they were eligible to switch over to receive pembrolizumab monotherapy Q3W for the remainder of the study.)"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"405"},{"groupId":"OG001","value":"202"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"112"},{"groupId":"OG001","value":"30"}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Progression-Free Survival (PFS) as Assessed by Investigator Immune-related RECIST (irRECIST) Response Criteria","description":"PFS was defined as the time from randomization to the first documented immune-related progressive disease (irPD) or death due to any cause, whichever occurred first. Per irRECIST, irPD was confirmed if any of the following are observed in 2 scans performed at least 4 weeks apart: target lesion sum of diameters remains ≥20 % and at least 5 mm absolute increase compared to nadir; non-target disease resulting in initial PD is qualitatively worse; new lesion resulting in initial irPD is qualitatively worse; additional new lesion(s) since last evaluation; or additional new non-target lesion progression since last evaluation. The PFS per irRECIST 1.1 is presented.","populationDescription":"The analysis population consisted of all randomized participants.","reportingStatus":"POSTED","paramType":"MEDIAN","dispersionType":"95% Confidence Interval","unitOfMeasure":"Months","timeFrame":"Up to approximately 39 months","groups":[{"id":"OG000","title":"Pembrolizumab+Pemetrexed+Platinum Chemotherapy Followed by Pembrolizumab+Pemetrexed","description":"Participants received pembrolizumab 200 mg IV PLUS pemetrexed 500 mg/m\\^2 IV (with vitamin supplementation) PLUS cisplatin 75 mg/m\\^2 IV OR carboplatin AUC 5 IV on Day 1 of every 3-week cycle (Q3W) for 4 cycles followed by pembrolizumab 200 mg IV PLUS pemetrexed 500 mg/m\\^2 IV Q3W until progression. (Participants who received pembrolizumab 200 mg IV Q3W for up to 2 years but experienced disease progression, were eligible to receive a second course of pembrolizumab monotherapy 200 mg IV Q3W, at the investigator's discretion, for up to 1 additional year.)"},{"id":"OG001","title":"Control","description":"Participants received saline placebo IV PLUS pemetrexed 500 mg/m\\^2 IV (with vitamin supplementation) PLUS cisplatin 75 mg/m\\^2 IV OR carboplatin AUC 5 IV on Day 1 of every 3-week cycle (Q3W) for 4 cycles followed by saline placebo IV PLUS pemetrexed 500 mg/m\\^2 IV Q3W until progression. (Effective 23-Dec-2019, participants discontinued saline placebo. If documented disease progression had occurred, and participants receiving Control met certain criteria, they were eligible to switch over to receive pembrolizumab monotherapy Q3W for the remainder of the study.)"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"410"},{"groupId":"OG001","value":"206"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"10.3","lowerLimit":"9.0","upperLimit":"11.3"},{"groupId":"OG001","value":"5.0","lowerLimit":"4.8","upperLimit":"6.0"}]}]}],"analyses":[{"groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY","pValue":"<0.00001","statisticalMethod":"Log Rank","paramType":"Hazard Ratio (HR)","paramValue":"0.49","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"0.41","ciUpperLimit":"0.59","estimateComment":"Based on Cox regression model with treatment as a covariate stratified by PD-L1 status (≥1% vs. \\<1%), platinum chemotherapy (cisplatin vs. carboplatin) \\& smoking status (never vs. former/current). Pembrolizumab=numerator; Control=denominator."}]}]},"adverseEventsModule":{"frequencyThreshold":"5","timeFrame":"Up to approximately 88 months","description":"Safety Population: All participants receiving ≥1 dose of randomized study drug. All-Cause Mortality Population: All randomized participants. Per protocol, progression of cancer under study was not considered an AE unless related to study drug. Therefore, MedDRA preferred terms \"Neoplasm progression\", \"Malignant neoplasm progression\" \\& \"Disease progression\" not related to study drug are excluded as AEs.","eventGroups":[{"id":"EG000","title":"Pembrolizumab+Pemetrexed+Platinum Chemotherapy Followed by Pembrolizumab+Pemetrexed","description":"Participants received pembrolizumab 200 mg IV PLUS pemetrexed 500 mg/m\\^2 IV (with vitamin supplementation) PLUS cisplatin 75 mg/m\\^2 IV OR carboplatin AUC 5 IV on Day 1 of every 3-week cycle (Q3W) for 4 cycles followed by pembrolizumab 200 mg IV PLUS pemetrexed 500 mg/m\\^2 IV Q3W until progression. (Participants who received pembrolizumab 200 mg IV Q3W for up to 2 years but experienced disease progression, were eligible to receive a second course of pembrolizumab monotherapy 200 mg IV Q3W, at the investigator's discretion, for up to 1 additional year.)","deathsNumAffected":330,"deathsNumAtRisk":410,"seriousNumAffected":233,"seriousNumAtRisk":405,"otherNumAffected":395,"otherNumAtRisk":405},{"id":"EG001","title":"Control","description":"Participants received saline placebo IV PLUS pemetrexed 500 mg/m\\^2 IV (with vitamin supplementation) PLUS cisplatin 75 mg/m\\^2 IV OR carboplatin AUC 5 IV on Day 1 of every 3-week cycle (Q3W) for 4 cycles followed by saline placebo IV PLUS pemetrexed 500 mg/m\\^2 IV Q3W until progression. (Effective 23-Dec-2019, participants discontinued saline placebo. If documented disease progression had occurred, and participants receiving Control met certain criteria, they were eligible to switch over to receive pembrolizumab monotherapy Q3W for the remainder of the study.)","deathsNumAffected":113,"deathsNumAtRisk":206,"seriousNumAffected":102,"seriousNumAtRisk":202,"otherNumAffected":196,"otherNumAtRisk":202},{"id":"EG002","title":"Control Switched Over to Pembrolizumab Monotherapy","description":"Qualified participants who received saline placebo with pemetrexed and platinum chemotherapy followed by placebo and pemetrexed, and who experienced disease progression, were switched over to receive pembrolizumab monotherapy 200 mg IV on Day 1 Q3W for up to 2 years.","deathsNumAffected":74,"deathsNumAtRisk":84,"seriousNumAffected":29,"seriousNumAtRisk":84,"otherNumAffected":64,"otherNumAtRisk":84},{"id":"EG003","title":"Control Switched Over to Pembrolizumab Monotherapy (Second Course)","description":"Participants who were switched from saline placebo to receive pembrolizumab monotherapy, and met certain criteria, received a second course of pembrolizumab monotherapy at 200 mg IV Q3W for up to 1 additional year.","deathsNumAffected":1,"deathsNumAtRisk":2,"seriousNumAffected":0,"seriousNumAtRisk":2,"otherNumAffected":2,"otherNumAtRisk":2},{"id":"EG004","title":"Pembrolizumab+Pemetrexed+Platinum Chemotherapy Followed by Pembrolizumab+Pemetrexed (Second Course)","description":"Participants who received pembrolizumab PLUS pemetrexed and platinum chemotherapy followed by pembrolizumab PLUS pemetrexed during the initial treatment but experienced disease progression, and met certain criteria, received a second course of pembrolizumab monotherapy at 200 mg IV Q3W for up to 1 additional year.","deathsNumAffected":4,"deathsNumAtRisk":9,"seriousNumAffected":2,"seriousNumAtRisk":9,"otherNumAffected":9,"otherNumAtRisk":9}],"seriousEvents":[{"term":"Anaemia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":14,"numAffected":13,"numAtRisk":405},{"groupId":"EG001","numEvents":12,"numAffected":11,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Disseminated intravascular coagulation","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":405},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Febrile neutropenia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":26,"numAffected":25,"numAtRisk":405},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":202},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Leukopenia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":405},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Lymphadenopathy","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Neutropenia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":11,"numAffected":11,"numAtRisk":405},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Pancytopenia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":405},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Thrombocytopenia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":14,"numAffected":13,"numAtRisk":405},{"groupId":"EG001","numEvents":6,"numAffected":6,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Acute myocardial infarction","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Atrial fibrillation","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Atrial flutter","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":405},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":202},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Cardiac arrest","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Cardiac failure","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Cardiopulmonary failure","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Left ventricular dysfunction","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Myocardial infarction","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Myopericarditis","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Pericardial effusion","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":202},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Pericarditis","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Sinus tachycardia","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Stress cardiomyopathy","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":405},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Supraventricular tachycardia","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Ventricular arrhythmia","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Adrenal insufficiency","organSystem":"Endocrine disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Hypothyroidism","organSystem":"Endocrine disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Abdominal adhesions","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Abdominal pain","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Abdominal pain upper","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Colitis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":5,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Colitis ulcerative","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Constipation","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":3,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":2,"numAffected":2,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Diarrhoea","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":16,"numAffected":14,"numAtRisk":405},{"groupId":"EG001","numEvents":8,"numAffected":5,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Duodenitis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Gastritis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Gastrointestinal perforation","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Gastrointestinal toxicity","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Impaired gastric emptying","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":405},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Intestinal ischaemia","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Intestinal pseudo-obstruction","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Intussusception","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Lip oedema","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Melaena","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Mesenteric artery embolism","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Nausea","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":5,"numAtRisk":405},{"groupId":"EG001","numEvents":7,"numAffected":7,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Neutropenic colitis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":405},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Oesophageal stenosis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":405},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Oesophagitis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Pancreatitis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Pancreatitis acute","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Pancreatitis chronic","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Small intestinal haemorrhage","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Stomatitis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":202},{"groupId":"EG002","numEvents":2,"numAffected":1,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Vomiting","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":8,"numAffected":7,"numAtRisk":405},{"groupId":"EG001","numEvents":5,"numAffected":5,"numAtRisk":202},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Asthenia","organSystem":"General disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":6,"numAffected":6,"numAtRisk":405},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Chest pain","organSystem":"General disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":405},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":202},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Death","organSystem":"General disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":405},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Fatigue","organSystem":"General disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"General physical health deterioration","organSystem":"General disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":6,"numAffected":6,"numAtRisk":405},{"groupId":"EG001","numEvents":3,"numAffected":2,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Inflammation","organSystem":"General disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Influenza like illness","organSystem":"General disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Localised oedema","organSystem":"General disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Malaise","organSystem":"General disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":405},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Mucosal inflammation","organSystem":"General disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":405},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Multiple organ dysfunction syndrome","organSystem":"General disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":405},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Oedema peripheral","organSystem":"General disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Pyrexia","organSystem":"General disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":10,"numAffected":9,"numAtRisk":405},{"groupId":"EG001","numEvents":5,"numAffected":5,"numAtRisk":202},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Autoimmune hepatitis","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Bile duct stone","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Cholangitis","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Cholangitis sclerosing","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Cholecystitis","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Hepatic pain","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Hepatitis","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Immune-mediated hepatitis","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Cytokine release syndrome","organSystem":"Immune system disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Abdominal sepsis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Appendicitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Arthritis bacterial","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Bacillus bacteraemia","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Bacteraemia","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Bacterial colitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Bronchitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":405},{"groupId":"EG001","numEvents":4,"numAffected":3,"numAtRisk":202},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"CNS ventriculitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"COVID-19 pneumonia","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Cellulitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":6,"numAffected":5,"numAtRisk":405},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Clostridium difficile colitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Clostridium difficile infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":405},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Diabetic foot infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":405},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Diverticulitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Empyema","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Encephalitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Endocarditis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Enteritis infectious","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Erysipelas","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":405},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Folliculitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Gastroenteritis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Herpes zoster","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Infected dermal cyst","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":405},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Infectious pleural effusion","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Infective exacerbation of chronic obstructive airways disease","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":2,"numAffected":2,"numAtRisk":9}]},{"term":"Influenza","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Kidney infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Lower respiratory tract infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":405},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Lung abscess","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":405},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Neutropenic sepsis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Oral candidiasis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Otitis media","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":405},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Parotitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Peritonitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Pneumococcal sepsis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Pneumocystis jirovecii pneumonia","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Pneumonia","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":35,"numAffected":34,"numAtRisk":405},{"groupId":"EG001","numEvents":21,"numAffected":18,"numAtRisk":202},{"groupId":"EG002","numEvents":4,"numAffected":4,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Pneumonia aspiration","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Pneumonia bacterial","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Pneumonia influenzal","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Pneumonia viral","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Pulmonary sepsis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":405},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Pyelonephritis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Respiratory syncytial virus infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Respiratory tract infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":405},{"groupId":"EG001","numEvents":2,"numAffected":1,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Salmonella bacteraemia","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":405},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Sepsis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":7,"numAffected":7,"numAtRisk":405},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":202},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Septic shock","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Tuberculosis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Tuberculous pleurisy","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Upper respiratory tract infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":6,"numAffected":6,"numAtRisk":405},{"groupId":"EG001","numEvents":5,"numAffected":2,"numAtRisk":202},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Upper respiratory tract infection bacterial","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Urinary tract infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":5,"numAtRisk":405},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":202},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Urosepsis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Accidental overdose","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Craniocerebral injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Dislocation of vertebra","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Fall","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":405},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":9}]},{"term":"Femoral neck fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":405},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Femur fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Hip fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Limb traumatic amputation","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Lumbar vertebral fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":405},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Post procedural diarrhoea","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":405},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Radiation oesophagitis","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Shoulder fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Spinal compression fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Spinal fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Toxicity to various agents","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Upper limb fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":405},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Wrist fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Alanine aminotransferase increased","organSystem":"Investigations","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Blood calcium decreased","organSystem":"Investigations","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Blood magnesium decreased","organSystem":"Investigations","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"C-reactive protein increased","organSystem":"Investigations","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Hepatic enzyme increased","organSystem":"Investigations","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Platelet count decreased","organSystem":"Investigations","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Decreased appetite","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":405},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Dehydration","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":7,"numAffected":5,"numAtRisk":405},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Diabetes mellitus inadequate control","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Hypercalcaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Hypokalaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":202},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Hypomagnesaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Hyponatraemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":405},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Malnutrition","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Polydipsia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Type 1 diabetes mellitus","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Type 2 diabetes mellitus","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Arthralgia","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Back pain","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":2,"numAffected":1,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Flank pain","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":405},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Groin pain","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":405},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Haematoma muscle","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Hypertrophic osteoarthropathy","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Muscular weakness","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Musculoskeletal chest pain","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":405},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Myalgia","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Neck pain","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Osteolysis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Osteonecrosis of jaw","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Pain in extremity","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":405},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Pathological fracture","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Adenocarcinoma of colon","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":405},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Bladder cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":405},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Cancer pain","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":405},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Malignant neoplasm progression","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":405},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Metastases to central nervous system","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Metastases to meninges","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Prostate cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Small cell lung cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Squamous cell carcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Thyroid cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Tracheal neoplasm","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":405},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Tumour pain","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Balance disorder","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Brain stem infarction","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Central nervous system vasculitis","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Cerebral haemorrhage","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":405},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Cerebral infarction","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Cerebrovascular accident","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Demyelinating polyneuropathy","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Dizziness","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":405},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Encephalopathy","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Haemorrhage intracranial","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":405},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Hemiparesis","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Hydrocephalus","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Intracranial aneurysm","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Ischaemic stroke","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":2,"numAtRisk":405},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Lacunar stroke","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Lumbar radiculopathy","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Partial seizures","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":405},{"groupId":"EG001","numEvents":2,"numAffected":1,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Seizure","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":405},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Spinal cord compression","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Syncope","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":405},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Transient ischaemic attack","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Device dislocation","organSystem":"Product Issues","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Anxiety","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Confusional state","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Delirium","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":405},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Depression","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Disorientation","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Major depression","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Acute kidney injury","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":11,"numAffected":11,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Autoimmune nephritis","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Chronic kidney disease","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Haematuria","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":405},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Nephritis","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Prerenal failure","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Renal failure","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Renal tubular necrosis","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Tubulointerstitial nephritis","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Urinary retention","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Urinary tract obstruction","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Balanoposthitis","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Scrotal cyst","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Atelectasis","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":405},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":202},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Chronic obstructive pulmonary disease","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":8,"numAffected":6,"numAtRisk":405},{"groupId":"EG001","numEvents":4,"numAffected":3,"numAtRisk":202},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Dyspnoea","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":6,"numAffected":6,"numAtRisk":405},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":202},{"groupId":"EG002","numEvents":5,"numAffected":4,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Epistaxis","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Haemoptysis","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":405},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Haemothorax","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Hiccups","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Obstructive airways disorder","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Obstructive sleep apnoea syndrome","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Pleural effusion","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":14,"numAffected":13,"numAtRisk":405},{"groupId":"EG001","numEvents":6,"numAffected":5,"numAtRisk":202},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Pneumonitis","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":13,"numAffected":13,"numAtRisk":405},{"groupId":"EG001","numEvents":5,"numAffected":5,"numAtRisk":202},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Pneumothorax","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":405},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Pulmonary embolism","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":5,"numAtRisk":405},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":202},{"groupId":"EG002","numEvents":4,"numAffected":3,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Pulmonary fibrosis","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Pulmonary haemorrhage","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Respiratory failure","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Dermatitis","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":405},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Rash","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Rash papular","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Skin sensitisation","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":405},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Stasis dermatitis","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Aortic stenosis","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":405},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Deep vein thrombosis","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":405},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":202},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Hypertension","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Jugular vein thrombosis","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":405},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Peripheral artery occlusion","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Vena cava thrombosis","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Venous occlusion","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":405},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]}],"otherEvents":[{"term":"Anaemia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":253,"numAffected":186,"numAtRisk":405},{"groupId":"EG001","numEvents":114,"numAffected":91,"numAtRisk":202},{"groupId":"EG002","numEvents":8,"numAffected":6,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Leukopenia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":44,"numAffected":26,"numAtRisk":405},{"groupId":"EG001","numEvents":18,"numAffected":13,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Neutropenia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":213,"numAffected":108,"numAtRisk":405},{"groupId":"EG001","numEvents":92,"numAffected":49,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Thrombocytopenia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":108,"numAffected":68,"numAtRisk":405},{"groupId":"EG001","numEvents":37,"numAffected":25,"numAtRisk":202},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Ear discomfort","organSystem":"Ear and labyrinth disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":405},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":9}]},{"term":"Otorrhoea","organSystem":"Ear and labyrinth disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":9}]},{"term":"Tinnitus","organSystem":"Ear and labyrinth disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":19,"numAffected":14,"numAtRisk":405},{"groupId":"EG001","numEvents":12,"numAffected":11,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Vertigo","organSystem":"Ear and labyrinth disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":21,"numAffected":17,"numAtRisk":405},{"groupId":"EG001","numEvents":7,"numAffected":4,"numAtRisk":202},{"groupId":"EG002","numEvents":2,"numAffected":1,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":9}]},{"term":"Hypothyroidism","organSystem":"Endocrine disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":38,"numAffected":31,"numAtRisk":405},{"groupId":"EG001","numEvents":7,"numAffected":5,"numAtRisk":202},{"groupId":"EG002","numEvents":6,"numAffected":6,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Dry eye","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":23,"numAffected":21,"numAtRisk":405},{"groupId":"EG001","numEvents":5,"numAffected":5,"numAtRisk":202},{"groupId":"EG002","numEvents":2,"numAffected":2,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Lacrimation increased","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":87,"numAffected":75,"numAtRisk":405},{"groupId":"EG001","numEvents":24,"numAffected":22,"numAtRisk":202},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Abdominal pain","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":49,"numAffected":39,"numAtRisk":405},{"groupId":"EG001","numEvents":14,"numAffected":13,"numAtRisk":202},{"groupId":"EG002","numEvents":7,"numAffected":7,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":2,"numAffected":2,"numAtRisk":9}]},{"term":"Abdominal pain upper","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":31,"numAffected":29,"numAtRisk":405},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Constipation","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":220,"numAffected":143,"numAtRisk":405},{"groupId":"EG001","numEvents":87,"numAffected":67,"numAtRisk":202},{"groupId":"EG002","numEvents":7,"numAffected":7,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Diarrhoea","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":179,"numAffected":123,"numAtRisk":405},{"groupId":"EG001","numEvents":54,"numAffected":41,"numAtRisk":202},{"groupId":"EG002","numEvents":19,"numAffected":11,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":2,"numAffected":2,"numAtRisk":9}]},{"term":"Dyspepsia","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":31,"numAffected":28,"numAtRisk":405},{"groupId":"EG001","numEvents":11,"numAffected":11,"numAtRisk":202},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Gastrooesophageal reflux disease","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":18,"numAffected":17,"numAtRisk":405},{"groupId":"EG001","numEvents":6,"numAffected":6,"numAtRisk":202},{"groupId":"EG002","numEvents":2,"numAffected":2,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":9}]},{"term":"Nausea","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":430,"numAffected":232,"numAtRisk":405},{"groupId":"EG001","numEvents":186,"numAffected":103,"numAtRisk":202},{"groupId":"EG002","numEvents":18,"numAffected":16,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":2,"numAffected":1,"numAtRisk":9}]},{"term":"Stomatitis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":54,"numAffected":37,"numAtRisk":405},{"groupId":"EG001","numEvents":21,"numAffected":16,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Vomiting","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":183,"numAffected":104,"numAtRisk":405},{"groupId":"EG001","numEvents":70,"numAffected":43,"numAtRisk":202},{"groupId":"EG002","numEvents":14,"numAffected":12,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":2,"numAffected":1,"numAtRisk":9}]},{"term":"Asthenia","organSystem":"General disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":158,"numAffected":85,"numAtRisk":405},{"groupId":"EG001","numEvents":74,"numAffected":47,"numAtRisk":202},{"groupId":"EG002","numEvents":8,"numAffected":6,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Chest pain","organSystem":"General disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":44,"numAffected":38,"numAtRisk":405},{"groupId":"EG001","numEvents":14,"numAffected":12,"numAtRisk":202},{"groupId":"EG002","numEvents":6,"numAffected":6,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Fatigue","organSystem":"General disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":285,"numAffected":173,"numAtRisk":405},{"groupId":"EG001","numEvents":127,"numAffected":80,"numAtRisk":202},{"groupId":"EG002","numEvents":9,"numAffected":8,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":9}]},{"term":"Mucosal inflammation","organSystem":"General disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":48,"numAffected":37,"numAtRisk":405},{"groupId":"EG001","numEvents":24,"numAffected":16,"numAtRisk":202},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Oedema peripheral","organSystem":"General disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":180,"numAffected":103,"numAtRisk":405},{"groupId":"EG001","numEvents":48,"numAffected":35,"numAtRisk":202},{"groupId":"EG002","numEvents":11,"numAffected":11,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Pain","organSystem":"General disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":22,"numAffected":22,"numAtRisk":405},{"groupId":"EG001","numEvents":7,"numAffected":7,"numAtRisk":202},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Pyrexia","organSystem":"General disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":118,"numAffected":84,"numAtRisk":405},{"groupId":"EG001","numEvents":47,"numAffected":30,"numAtRisk":202},{"groupId":"EG002","numEvents":7,"numAffected":6,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Bronchitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":29,"numAffected":23,"numAtRisk":405},{"groupId":"EG001","numEvents":7,"numAffected":6,"numAtRisk":202},{"groupId":"EG002","numEvents":2,"numAffected":2,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Conjunctivitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":48,"numAffected":37,"numAtRisk":405},{"groupId":"EG001","numEvents":33,"numAffected":18,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Ear infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":9}]},{"term":"Herpes zoster","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":12,"numAffected":11,"numAtRisk":405},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":202},{"groupId":"EG002","numEvents":2,"numAffected":2,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":9}]},{"term":"Nasopharyngitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":76,"numAffected":47,"numAtRisk":405},{"groupId":"EG001","numEvents":12,"numAffected":10,"numAtRisk":202},{"groupId":"EG002","numEvents":6,"numAffected":5,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":2,"numAffected":2,"numAtRisk":9}]},{"term":"Otitis externa","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":9}]},{"term":"Pneumonia","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":29,"numAffected":21,"numAtRisk":405},{"groupId":"EG001","numEvents":6,"numAffected":6,"numAtRisk":202},{"groupId":"EG002","numEvents":2,"numAffected":2,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Sinusitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":12,"numAffected":10,"numAtRisk":405},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":202},{"groupId":"EG002","numEvents":3,"numAffected":2,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":9}]},{"term":"Upper respiratory tract infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":59,"numAffected":44,"numAtRisk":405},{"groupId":"EG001","numEvents":17,"numAffected":16,"numAtRisk":202},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":9}]},{"term":"Urinary tract infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":47,"numAffected":34,"numAtRisk":405},{"groupId":"EG001","numEvents":17,"numAffected":13,"numAtRisk":202},{"groupId":"EG002","numEvents":6,"numAffected":4,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Contusion","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":6,"numAffected":6,"numAtRisk":405},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":2,"numAffected":1,"numAtRisk":9}]},{"term":"Skin abrasion","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":9}]},{"term":"Alanine aminotransferase increased","organSystem":"Investigations","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":63,"numAffected":50,"numAtRisk":405},{"groupId":"EG001","numEvents":23,"numAffected":19,"numAtRisk":202},{"groupId":"EG002","numEvents":4,"numAffected":4,"numAtRisk":84},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Aspartate aminotransferase increased","organSystem":"Investigations","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":57,"numAffected":40,"numAtRisk":405},{"groupId":"EG001","numEvents":16,"numAffected":13,"numAtRisk":202},{"groupId":"EG002","numEvents":6,"numAffected":5,"numAtRisk":84},{"groupId":"EG003","numEvents":2,"numAffected":1,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Blood alkaline phosphatase increased","organSystem":"Investigations","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":21,"numAffected":16,"numAtRisk":405},{"groupId":"EG001","numEvents":11,"numAffected":9,"numAtRisk":202},{"groupId":"EG002","numEvents":2,"numAffected":2,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":9}]},{"term":"Blood bilirubin increased","organSystem":"Investigations","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Blood creatinine increased","organSystem":"Investigations","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":97,"numAffected":58,"numAtRisk":405},{"groupId":"EG001","numEvents":29,"numAffected":17,"numAtRisk":202},{"groupId":"EG002","numEvents":10,"numAffected":4,"numAtRisk":84},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Blood magnesium decreased","organSystem":"Investigations","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":405},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":9}]},{"term":"Tri-iodothyronine increased","organSystem":"Investigations","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":9}]},{"term":"Weight decreased","organSystem":"Investigations","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":59,"numAffected":44,"numAtRisk":405},{"groupId":"EG001","numEvents":17,"numAffected":16,"numAtRisk":202},{"groupId":"EG002","numEvents":4,"numAffected":4,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"White blood cell count decreased","organSystem":"Investigations","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":57,"numAffected":28,"numAtRisk":405},{"groupId":"EG001","numEvents":20,"numAffected":13,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Decreased appetite","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":172,"numAffected":122,"numAtRisk":405},{"groupId":"EG001","numEvents":81,"numAffected":63,"numAtRisk":202},{"groupId":"EG002","numEvents":19,"numAffected":17,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Hyperglycaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":49,"numAffected":34,"numAtRisk":405},{"groupId":"EG001","numEvents":10,"numAffected":7,"numAtRisk":202},{"groupId":"EG002","numEvents":2,"numAffected":2,"numAtRisk":84},{"groupId":"EG003","numEvents":2,"numAffected":1,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Hypokalaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":91,"numAffected":51,"numAtRisk":405},{"groupId":"EG001","numEvents":20,"numAffected":16,"numAtRisk":202},{"groupId":"EG002","numEvents":2,"numAffected":2,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Hypomagnesaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":54,"numAffected":37,"numAtRisk":405},{"groupId":"EG001","numEvents":14,"numAffected":8,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":9}]},{"term":"Hypophosphataemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":38,"numAffected":24,"numAtRisk":405},{"groupId":"EG001","numEvents":13,"numAffected":5,"numAtRisk":202},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Arthralgia","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":99,"numAffected":70,"numAtRisk":405},{"groupId":"EG001","numEvents":33,"numAffected":28,"numAtRisk":202},{"groupId":"EG002","numEvents":12,"numAffected":10,"numAtRisk":84},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":2},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":9}]},{"term":"Back pain","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":86,"numAffected":71,"numAtRisk":405},{"groupId":"EG001","numEvents":29,"numAffected":26,"numAtRisk":202},{"groupId":"EG002","numEvents":7,"numAffected":7,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Musculoskeletal chest pain","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":23,"numAffected":19,"numAtRisk":405},{"groupId":"EG001","numEvents":7,"numAffected":7,"numAtRisk":202},{"groupId":"EG002","numEvents":2,"numAffected":2,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":9}]},{"term":"Musculoskeletal pain","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":13,"numAffected":10,"numAtRisk":405},{"groupId":"EG001","numEvents":9,"numAffected":8,"numAtRisk":202},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":84},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Neck pain","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":16,"numAffected":16,"numAtRisk":405},{"groupId":"EG001","numEvents":8,"numAffected":6,"numAtRisk":202},{"groupId":"EG002","numEvents":4,"numAffected":4,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":9}]},{"term":"Osteoarthritis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Pain in extremity","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":47,"numAffected":37,"numAtRisk":405},{"groupId":"EG001","numEvents":18,"numAffected":18,"numAtRisk":202},{"groupId":"EG002","numEvents":7,"numAffected":6,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":9}]},{"term":"Dizziness","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":64,"numAffected":58,"numAtRisk":405},{"groupId":"EG001","numEvents":27,"numAffected":22,"numAtRisk":202},{"groupId":"EG002","numEvents":2,"numAffected":2,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Dysgeusia","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":41,"numAffected":36,"numAtRisk":405},{"groupId":"EG001","numEvents":17,"numAffected":17,"numAtRisk":202},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Headache","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":72,"numAffected":57,"numAtRisk":405},{"groupId":"EG001","numEvents":29,"numAffected":22,"numAtRisk":202},{"groupId":"EG002","numEvents":7,"numAffected":5,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Paraesthesia","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":33,"numAffected":24,"numAtRisk":405},{"groupId":"EG001","numEvents":21,"numAffected":14,"numAtRisk":202},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Radiculopathy","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":9}]},{"term":"Insomnia","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":35,"numAffected":31,"numAtRisk":405},{"groupId":"EG001","numEvents":17,"numAffected":17,"numAtRisk":202},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":9}]},{"term":"Proteinuria","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":405},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":3,"numAffected":2,"numAtRisk":9}]},{"term":"Cough","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":139,"numAffected":104,"numAtRisk":405},{"groupId":"EG001","numEvents":71,"numAffected":62,"numAtRisk":202},{"groupId":"EG002","numEvents":13,"numAffected":9,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":2,"numAffected":2,"numAtRisk":9}]},{"term":"Dyspnoea","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":118,"numAffected":97,"numAtRisk":405},{"groupId":"EG001","numEvents":59,"numAffected":51,"numAtRisk":202},{"groupId":"EG002","numEvents":20,"numAffected":15,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":9}]},{"term":"Epistaxis","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":35,"numAffected":29,"numAtRisk":405},{"groupId":"EG001","numEvents":11,"numAffected":7,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Haemoptysis","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":16,"numAffected":14,"numAtRisk":405},{"groupId":"EG001","numEvents":20,"numAffected":16,"numAtRisk":202},{"groupId":"EG002","numEvents":2,"numAffected":2,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Oropharyngeal pain","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":33,"numAffected":27,"numAtRisk":405},{"groupId":"EG001","numEvents":6,"numAffected":6,"numAtRisk":202},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Productive cough","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":33,"numAffected":27,"numAtRisk":405},{"groupId":"EG001","numEvents":10,"numAffected":9,"numAtRisk":202},{"groupId":"EG002","numEvents":4,"numAffected":3,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":9}]},{"term":"Rhinorrhoea","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":28,"numAffected":25,"numAtRisk":405},{"groupId":"EG001","numEvents":10,"numAffected":10,"numAtRisk":202},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":9}]},{"term":"Wheezing","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":11,"numAffected":10,"numAtRisk":405},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":202},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":9}]},{"term":"Alopecia","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":24,"numAffected":22,"numAtRisk":405},{"groupId":"EG001","numEvents":10,"numAffected":10,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Dry skin","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":28,"numAffected":27,"numAtRisk":405},{"groupId":"EG001","numEvents":22,"numAffected":20,"numAtRisk":202},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":9}]},{"term":"Erythema","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":38,"numAffected":30,"numAtRisk":405},{"groupId":"EG001","numEvents":5,"numAffected":4,"numAtRisk":202},{"groupId":"EG002","numEvents":3,"numAffected":3,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Pruritus","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":80,"numAffected":59,"numAtRisk":405},{"groupId":"EG001","numEvents":25,"numAffected":23,"numAtRisk":202},{"groupId":"EG002","numEvents":4,"numAffected":4,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":9}]},{"term":"Rash","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":131,"numAffected":89,"numAtRisk":405},{"groupId":"EG001","numEvents":36,"numAffected":27,"numAtRisk":202},{"groupId":"EG002","numEvents":4,"numAffected":4,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]},{"term":"Skin ulcer","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":405},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":202},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":9}]},{"term":"Hypertension","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":25,"numAffected":23,"numAtRisk":405},{"groupId":"EG001","numEvents":14,"numAffected":11,"numAtRisk":202},{"groupId":"EG002","numEvents":6,"numAffected":5,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":2,"numAffected":2,"numAtRisk":9}]},{"term":"Hypotension","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 26.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":27,"numAffected":24,"numAtRisk":405},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":202},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":84},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":9}]}]},"moreInfoModule":{"certainAgreement":{"piSponsorEmployee":false,"restrictionType":"OTHER","restrictiveAgreement":true,"otherDetails":"The Sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission; this confidentiality does not include efficacy and safety results. Sponsor review can be expedited to meet publication timelines."},"pointOfContact":{"title":"Senior Vice President, Global Clinical Development","organization":"Merck Sharp & Dohme LLC","email":"ClinicalTrialsDisclosure@msd.com","phone":"1-800-672-6372"}}},"documentSection":{"largeDocumentModule":{"largeDocs":[{"typeAbbrev":"Prot_SAP","hasProtocol":true,"hasSap":true,"hasIcf":false,"label":"Study Protocol and Statistical Analysis Plan","date":"2022-05-31","uploadDate":"2024-06-14T13:34","filename":"Prot_SAP_001.pdf","size":2369337}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2025-12-17","removedCountries":["Australia","Austria","Belgium","Canada","Denmark","Finland","France","Germany","Ireland","Israel","Italy","Japan","Netherlands","Spain","United Kingdom","United States"]},"conditionBrowseModule":{"meshes":[{"id":"D002289","term":"Carcinoma, Non-Small-Cell Lung"}],"ancestors":[{"id":"D002283","term":"Carcinoma, Bronchogenic"},{"id":"D001984","term":"Bronchial Neoplasms"},{"id":"D008175","term":"Lung Neoplasms"},{"id":"D012142","term":"Respiratory Tract Neoplasms"},{"id":"D013899","term":"Thoracic Neoplasms"},{"id":"D009371","term":"Neoplasms by Site"},{"id":"D009369","term":"Neoplasms"},{"id":"D008171","term":"Lung Diseases"},{"id":"D012140","term":"Respiratory Tract Diseases"}]},"interventionBrowseModule":{"meshes":[{"id":"C582435","term":"pembrolizumab"},{"id":"D002945","term":"Cisplatin"},{"id":"D016190","term":"Carboplatin"},{"id":"D000068437","term":"Pemetrexed"},{"id":"D005492","term":"Folic Acid"},{"id":"D014805","term":"Vitamin B 12"},{"id":"D003907","term":"Dexamethasone"},{"id":"D000077330","term":"Saline Solution"}],"ancestors":[{"id":"D017606","term":"Chlorine Compounds"},{"id":"D007287","term":"Inorganic Chemicals"},{"id":"D017672","term":"Nitrogen Compounds"},{"id":"D017671","term":"Platinum Compounds"},{"id":"D056831","term":"Coordination Complexes"},{"id":"D009930","term":"Organic Chemicals"},{"id":"D006147","term":"Guanine"},{"id":"D007042","term":"Hypoxanthines"},{"id":"D011688","term":"Purinones"},{"id":"D011687","term":"Purines"},{"id":"D006574","term":"Heterocyclic Compounds, 2-Ring"},{"id":"D000072471","term":"Heterocyclic Compounds, Fused-Ring"},{"id":"D006571","term":"Heterocyclic Compounds"},{"id":"D005971","term":"Glutamates"},{"id":"D024342","term":"Amino Acids, Acidic"},{"id":"D000596","term":"Amino Acids"},{"id":"D000602","term":"Amino Acids, Peptides, and Proteins"},{"id":"D000600","term":"Amino Acids, Dicarboxylic"},{"id":"D011622","term":"Pterins"},{"id":"D011621","term":"Pteridines"},{"id":"D045728","term":"Corrinoids"},{"id":"D045725","term":"Tetrapyrroles"},{"id":"D011758","term":"Pyrroles"},{"id":"D001393","term":"Azoles"},{"id":"D006573","term":"Heterocyclic Compounds, 1-Ring"},{"id":"D006576","term":"Heterocyclic Compounds, 4 or More Rings"},{"id":"D047028","term":"Macrocyclic Compounds"},{"id":"D011083","term":"Polycyclic Compounds"},{"id":"D011246","term":"Pregnadienetriols"},{"id":"D011245","term":"Pregnadienes"},{"id":"D011278","term":"Pregnanes"},{"id":"D013256","term":"Steroids"},{"id":"D000072473","term":"Fused-Ring Compounds"},{"id":"D013259","term":"Steroids, Fluorinated"},{"id":"D000077324","term":"Crystalloid Solutions"},{"id":"D007552","term":"Isotonic Solutions"},{"id":"D012996","term":"Solutions"},{"id":"D004364","term":"Pharmaceutical Preparations"}]}},"hasResults":true}